• Molecular NameSuramin
  • SynonymBayer 205; Sodium suramin; Suramin sodium; Suramine; Suramine sodium; SVR
  • Weight1297.3
  • Drugbank_IDDB04786
  • ACS_NO145-63-1
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)N/A
  • pkaN/A
  • LogD (pH=7, predicted)N/A
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)N/A
  • LogSw (predicted, AB/LogsW2.0)N/A
  • Sw (mg/ml) (predicted, ACD/Labs)N/A
  • No.of HBond DonorsN/A
  • No.of HBond AcceptorsN/A
  • No.of Rotatable BondsN/A
  • TPSAN/A
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyIt is used for treatment of human sleeping sickness caused by trypanosomes.
  • Absorption_valueN/A
  • Absorption (description)Poorly absorbed from the gastrointestinal tract.
  • Caco_2N/A
  • Bioavailability0.0
  • Protein binding99.7
  • Volume of distribution (VD)0.44~0.66 mg/ml
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmLittle or no metabolism
  • Half life36~60 days
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A